LeMaitre Vascular reported second quarter 2026 sales of US$70.38 million, up from US$64.23 million a year earlier, with net income rising to US$17.05 million from US$13.78 million. Diluted earnings per share from continuing operations were US$0.74 compared with US$0.60 in the prior year period. For the first six months of 2026, sales reached US$136.93 million versus US$124.10 million, and net income was US$32.73 million against US$24.79 million. The company also issued new earnings guidance and affirmed its quarterly dividend. The results come amid a 20% share price decline over the past 30 days, with analysts estimating a fair value of US$118.75 per share, suggesting the stock is 31.4% undervalued relative to the latest close of US$81.45.
LeMaitre Vascular IncHigher Q2 sales and net income, new guidance, and affirmed dividend are positive financial results.
